Is SCNI diluting shareholders?

Read three numbers together: shares outstanding over time (13.87B as of 2025-12-31), warrants that can convert into new shares (2.6M reported), and how much cash runway remains (~3.3049245564582987 months). A company short on cash with live registrations is structurally likely to issue shares.

Where do these numbers come from?

SEC EDGAR only: the XBRL company-facts API for shares, warrants and cash, and filing metadata for registrations and pricings. Every figure shows its source form, and nothing here is estimated by us beyond the arithmetic stated next to it.

Why might a warrant tranche be missing from the table?

The tranche table is built from the dimensions the company tagged in its own 10-Q or 10-K XBRL. A tranche the filer chose not to dimension does not appear, and its absence proves nothing: the exhibits remain the ground truth. Everything shown carries the filing it came from.

Dilution profile // every instrument, one screen, from SEC filings

Scinai Immunotherapeutics Ltd. (SCNI)

CIK 1611747 · all EDGAR filings →

Overall dilution risk

HIGHworst of 4 computed signals (offering ability)

= the worst band among the computed sub-ratings, no hidden weighting

Offering ability

HIGH$20.8M registered

= total registered offering amount from the fee exhibits of live registrations (bands: $1M / $20M)

one or more live registrations had no structured fee data, so the true total is AT LEAST this

Overhead supply

LOWwarrants = 0% of O/S

= warrant shares outstanding divided by current shares outstanding (bands: 20% / 50%)

warrants only; converts, ATMs and equity lines are not in free structured data, so the true overhead is AT LEAST this

Historical dilution

HIGH+956% O/S in 3y

= share count now vs 3 years ago (bands: 30% / 100%); a reverse split pushes this negative

Cash need

HIGH~3.3 months of runway

= cash vs trailing operating burn (bands: 6mo / 24mo; positive operating CF = low)

Same rating bands the category standard uses, but free, with the formula on the chip and the gaps in the data said out loud.

Shares outstanding over time

Latest: 13.87B shares as of Dec 31, 2025 (20-F).

Cash runway

~3 months of cash left

critical · burning $1.5M / quarter

Full breakdown: cash runway tool · source filing →

Warrants

Warrants outstanding: 2.6M underlying shares, as reported Jan 4, 2024 (6-K).

Reported exercise price: $0.65 (aggregate figure as tagged; individual tranches vary).

Balance-sheet fair value of warrants: $3,000 as of Jun 30, 2025.

Rough fully diluted estimate: 13.88B = 13.87B O/S + 2.6M warrant shares. An estimate, not a filing figure: it ignores converts, options and RSUs, and the two inputs carry different as-of dates.

Convertible notes

No convertible-note facts tagged in the 10-Q filed May 15, 2023. If convertible notes exist, their terms live in exhibit prose for this filer and are not parsed; absence of a tag is not proof of absence. The exhibits are the ground truth.

Fully diluted build-up

Shares outstanding plus every potential-share instrument the filer tagged in XBRL, each at its own as-of date. An estimate assembled from filed figures, not a filing figure itself.

Shares outstanding	13.87B	Dec 31, 2025
+ Warrants (aggregate, as tagged) (if exercised)	2.6M	Jan 4, 2024
Fully diluted estimate	13.88B	+0.0% vs O/S

Still excluded, because the filer does not tag them in countable form: employee options and RSUs, any instrument living only in exhibit prose, and instruments above missing a share count. Inputs carry different as-of dates, shown per row. Each figure traces to the tranche and note tables above and their cited filings.

Registrations and offerings

Registered offering capacity on live registrations: $20.8Mfrom the structured fee exhibits; registered is not remaining, takedowns are not subtracted

F-3May 8, 2026$13.1M registeredfiling →

F-1Sep 22, 2025$7.7M registeredfiling →

F-1Mar 4, 2025no structured fee exhibit in this filing (predates fee-data XBRL or fee deferred)filing →

Last 12 months: 0 executed · 2 registered.

UPDATEMay 19, 2026Prospectus update — often a resale registration, not necessarily new capital424B3 →

EFFECTIVEMay 19, 2026SEC declared a registration effective — selling can beginEFFECT →

REGISTEREDMay 8, 2026F-3 registration — capacity to sell shares, not a sale yetF-3 →

UPDATEOct 6, 2025Prospectus update — often a resale registration, not necessarily new capital424B3 →

EFFECTIVESep 30, 2025SEC declared a registration effective — selling can beginEFFECT →

REGISTEREDSep 22, 2025F-1 registration — capacity to sell shares, not a sale yetF-1 →

EFFECTIVESep 8, 2025SEC declared a registration effective — selling can beginEFFECT →

UPDATEJun 5, 2025Prospectus update — often a resale registration, not necessarily new capital424B3 →

EFFECTIVEMay 15, 2025SEC declared a registration effective — selling can beginEFFECT →

UPDATEMar 13, 2025Prospectus update — often a resale registration, not necessarily new capital424B3 →

EFFECTIVEMar 12, 2025SEC declared a registration effective — selling can beginEFFECT →

REGISTEREDMar 11, 2025F-1/A registration — capacity to sell shares, not a sale yetF-1/A →

Full history and shelf status: offering checker · S-3 shelf checker

Source: SEC EDGAR XBRL company facts and filing metadata, fetched live and cached briefly. Share counts are cover-page figures with their form named. Warrant tranches and convertible notes come from the dimensioned facts in the latest 10-Q/10-K instance document, exactly as the company tagged them; untagged tranches and notes are absent, not disproven. Nothing on this page is manually verified and nothing is behind a login: what free data supports is shown, what it cannot support is stated. Not investment advice.

Keep going: float checker · offering calendar · short-squeeze screener · full SCNI workspace